Kamal Hamed

Kamal Hamed

Inga fler pågående positioner
65 år
Health Technology
Consumer Services

Profil

Kamal Hamed currently works at Spero Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Hamed also formerly worked at Novartis, Inc., as Head-Therapeutic Area from 2005 to 2017, Basilea Pharmaceutica AG, as Head-Clinical Development & Medical Affairs from 2017 to 2022, and Lysovant Sciences, Inc., as Chief Medical Officer in 2022.
Dr. Hamed received his graduate degree from The Johns Hopkins University, Masters Business Admin degree from the University of South Florida, and doctorate degree from American University of Beirut.

Tidigare kända positioner av Kamal Hamed

FöretagPositionSlut
SPERO THERAPEUTICS, INC. Teknisk/Vetenskaplig/F&U Direktör 2024-08-01
Lysovant Sciences, Inc.
Teknisk/Vetenskaplig/F&U Direktör 2022-08-01
BASILEA PHARMACEUTICA AG Teknisk/Vetenskaplig/F&U Direktör 2022-02-01
Företagsledare/Principal 2017-03-01
Se detaljerna i Kamal Hameds erfarenhet

Kamal Hameds utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

9

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Lysovant Sciences, Inc.

  1. Börsen
  2. Insiders
  3. Kamal Hamed